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1525-0016/$Accurate measurement of gene transfer into hematopoietic progenitor cells is an essential
prerequisite for assessing the utility of gene therapy approaches designed to correct hematologic
defects. We developed a reliable method to measure transduction efficiency at the level of the
progenitor cell with real-time polymerase chain reaction (PCR) analysis of individual progenitor-
derived colonies. We hypothesized that this method would demonstrate better sensitivity and
specificity than are currently achievable with conventional PCR. An oncoretroviral vector containing
the enhanced green fluorescent protein was used to transduce human CD34+ cells derived from
bone marrow or granulocyte-colony-stimulating factor-mobilized peripheral blood. Progenitor
assays were set up and colonies plucked after visualization by fluorescence microscopy. By analyzing
microscopically identified fluorescent samples and nontransduced samples, we calculated an overall
sensitivity and specificity of 90.2 and 95.0%, respectively. Real-time PCR had higher specificity and
sensitivity than conventional PCR as analyzed by generalized linear models ( P = 0.002 and P = 0.019,
respectively). In conclusion, we found real-time PCR to have superior sensitivity and specificity
compared to conventional PCR in determining transduction efficiency of hematopoietic progenitor
cells.R
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Determination of gene-transfer efficiency is a critically
important element of preclinical and clinical gene therapy
trials. In many preclinical settings, a marking gene such as
enhanced green fluorescent protein (EGFP) is incorpo-
rated along with the btherapeutic geneQ into the vector.
Transduction efficiency can then be determined easily by
flow cytometric analysis. However, expression of a foreign
protein such as EGFP is not utilized in clinical trials due to
the immunogenic nature of this foreign protein [1].THERAPY Vol. 11, No. 3, March 2005
e American Society of Gene Therapy
.00Because hematopoietic stem and progenitor cells are a
common target in human gene therapy protocols, anal-
ysis of transduction efficiency into committed progenitor
cells, in addition to differentiated cells, can be especially
informative to investigators. In the short-term follow-up
of patients, transduction of committed progenitor cells
does not necessarily reflect whether a hematopoietic stem
cell was transduced. However, the presence of transduced
progenitors in the long-term follow-up of patients is
consistent with transduction of a hematopoietic stem
cell. The most common methodology for estimating gene483
FIG. 1. Determination of the minimal number of HEL-EGFP-1 cells detectable
by real-time PCR. The HEL-EGFP-1 cells contain ~1 copy of the MFG-EGFP
provirus per genome. Samples were prepared by serial dilution of HEL-EGFP-1
cells into nontransduced HEL cells and were analyzed by real-time PCR. The
data points represent the mean Ct values with standard deviation. Ct value i
plotted against the number of single-copy HEL cells on a logarithmic scale
Linear regression analysis is shown as a solid line. This is representative of three
independent experiments.
METHOD doi:10.1016/j.ymthe.2004.10.017transfer into hematopoietic progenitor cells in clinical
protocols is conventional DNA PCR analysis of individual
progenitor-derived colonies. Performing PCR on individ-
ual colonies grown in methylcellulose, however, is labor
intensive, time consuming, and subject to false positives.
Stray cells or DNA, not derived from a colony, can
inadvertently be captured while harvesting individual
colonies, which can result in an unacceptable rate of false
positives due to the sensitivity of PCR. In addition, the
presence of methylcellulose can disrupt the polymerase
chain reaction, requiring additional labor-intensive han-
dling such as additional washing and DNA extraction
prior to running the PCR.
Real-time PCR, because of its high sensitivity, effi-
ciency, and capacity for accurate quantification, has
recently been employed to measure gene-transfer effi-
ciency. Real-time PCR utilizes a Taq polymerase and a set
of primers that cleave a fluorogenic probe bound to the
transgene internal to the primers. The resulting fluores-
cence is measured as the probe is cleaved and is propor-
tional to the amount of amplified DNA, thus allowing for
accurate quantification of copy number and, therefore,
transduction efficiency. Samples with a greater amount of
amplified DNA emit a fluorescent signal that reaches the
threshold level at an earlier PCR cycle number (referred to
as cycle threshold (Ct)). The computer software calculates
the Ct value by generating a graph of cycle number versus
mean fluorescence. This allows for a quantitative readout
rather than visualization of bands produced by gel
electrophoresis. Based on statistical analysis of the differ-
ences in Ct values, it is possible to discriminate trans-
duced colonies from false positives caused by stray DNA.
In addition, this technology can detect multiple target
DNA sequences during the PCR in a 96-well format and
thus is capable of rapidly screening many progenitor
colonies and controls.
The performance of real-time PCR has been shown to
be comparable to that of conventional PCR in the
detection of a multitude of different infectious pathogens
from human patients [2–5]. When performed with appro-
priate internal controls, real-time PCR is also capable of
accurately measuring vector titer and estimating gene-
transfer efficiency in a variety of cell lines [6–8]. To
estimate retroviral transduction efficiency into hemato-
poietic progenitor cells, Gerard et al. applied real-time
PCR methods to progenitor-derived colonies grown in a
methylcellulose culture system [9]. They demonstrated
that single colonies could be picked from methylcellulose,
placed into a cell lysis solution, added to a prefilled plate
of PCR reagents, and run on a real-time PCR machine to
determine gene-transfer efficiency. To date, however, no
systematic comparison of real-time PCR with conven-
tional DNA PCR for the measurement of transduction
efficiency in progenitor colonies has been performed.
We developed a novel method for measuring gene-
transfer efficiency into hematopoietic progenitor cells by484applying a relatively simple statistical analysis to real-time
PCR data generated from individual progenitor-derived
colonies. We hypothesized that by coupling statistical
analysis with real-time PCR data, we could correct for false
positives, resulting in a method with greater specificity
compared to conventional PCR. We then compared the
sensitivity and specificity of this method to those of
conventional PCR by analyzing individual colonies
derived from human CD34+ cells transduced with a
retroviral vector containing the EGFP sequence. These
studies demonstrate that real-time PCR is a valid assay for
detection of gene transfer into human hematopoietic
progenitor colonies with superior levels of sensitivity and
specificity compared to conventional PCR.
RESULTS
Determination of the Minimal Number of
Provirus-positive Cells Detected by Real-Time PCR
To determine if the amplification of proviral sequences
by real-time PCR was in the detection range required for
analysis of progenitor colonies, we performed a serial
dilution experiment using a human erythroid leukemic
(HEL) cell line, HEL-EGFP-1, that contains ~1 copy of the
MFG-EGFP provirus per genome (see Materials and
Methods). With the assumption that a typical progenitor
colony will contain at least 50 cells, we diluted HEL-
EGFP-1 cells serially into nontransduced HEL cells and
transferred them to a 96-well plate, resulting in cell
concentrations ranging from 10 to 10,000 cells/well in
triplicate. We then took one-fifth of each DNA sample for
amplification and sequence detection by real-time PCR.
These volumes were identical to those used for analysis ofMOLECULAR THERAPY Vol. 11, No. 3, March 2005
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TABLE 1: Descriptive statistics for MMLV Ct
onor Samples N Mean Median SD
M001 F 20 32.71 32.02 3.85
NF 20 39.97 40 0.14
NT 20 40 40 0
M005 F 25 31 30.87 4.37
NF 12 38.06 40 3.51
NT 21 40 40 0
M006 F 27 31.23 30.3 4.83
NF 12 35.52 35.26 4.42
NT 9 38.26 40 2.82
M007 F 26 30.19 29.91 2.88
NF 30 37.88 39.31 2.98
NT 5 38.7 40 2.91
M008 F 24 33.23 32.9 3.47
NF 23 37.49 40 3.53
NT 5 37.18 40 3.88
M009 F 24 28.08 28.1 2.15
NT 24 33.59 33.45 0.51
M012 F 20 29.98 30.04 1.61
NF 20 38.55 40 3.14
NT 20 39.88 40 0.42
PB02_1 F 12 29.03 29 3.5
NF 11 39 40 1.65
NT 6 39.01 40 1.7
PB02_2 F 20 28.92 29.25 1.94
NF 22 36.01 37.09 4.17
NT 14 39.85 40 0.43
PB04_1 F 20 29.81 30.69 3.12
NF 20 35.14 34.14 3.41
NT 20 39.61 40 1.05
PB04_2 F 20 27.93 28.52 3.11
NF 19 34.72 34.37 4.13
NT 20 39.94 40 0.29
otal F 238 30.29 29.98 3.68
NF 189 37.23 39.94 3.65
NT 164 38.72 40 2.49
M, bone marrow donor sample; F, fluorescent colony; NF, nonfluorescent colony; NT,
ontransduced colony; MPB, G-CSF-mobilized peripheral blood sample.
METHODdoi:10.1016/j.ymthe.2004.10.017DNA from progenitor colonies. The smallest number of
HEL-EGFP-1 cells detected by real-time PCR was 50 cells/
well (10 cells/reaction) (Fig. 1), which is in the range
needed for detection of transduced progenitor colonies.
Nontransduced cells and culture medium-only samples
were uniformly negative. In addition, to determine if the
addition of methylcellulose negatively impacted the real-
time polymerase chain reaction, we performed experi-
ments in which 3 Al of methylcellulose was added to the
real-time PCR containing HEL-EGFP-1 DNA. Three micro-
liters of methylcellulose is typically the volume of
methylcellulose harvested when plucking colonies (see
Materials and Methods). In two separate experiments, the
addition of the methylcellulose to the samples did not
change the Ct values compared to samples not spiked
with methylcellulose (data not shown).
Distribution of Ct Values From Real-Time PCR
Analysis of Fluorescent (F), Nonfluorescent (NF), and
Nontransduced (NT) Progenitor Colonies
Prestimulated human CD34+ cells derived from bone
marrow (BM) or granulocyte-colony-stimulating factor
(G-CSF)-mobilized peripheral blood (MPB) were trans-
duced on Retronectin-coated plates with the MFG-EGFP
retrovirus as described under Materials and Methods. NT
cells were mock transduced on Retronectin-coated plates
and not exposed to virus. Since the frequency of
committed progenitor cells can vary from donor to
donor, aliquots of cells were always plated in complete
methylcellulose at 250, 500, and 1000 cells/ml so that
plucking of progenitor colonies was performed from
plates with ~30 colonies or less. We found this decreased
the chances of contamination from stray DNA or from
adjacent colonies since the colonies were well separated
and could be easily plucked. We performed fluorescence
microscopy and real-time PCR on progenitor colonies
and compared them in 11 independent experiments
(Table 1 and Fig. 2). In the plates containing transduced
progenitor colonies, the number of F versus NF colonies
was first determined by fluorescence microscopy. As a
control, analysis of the NT progenitor colonies by
fluorescence microscopy indicated that all colonies were
negative for EGFP-mediated fluorescence. We plucked the
colonies and analyzed them by real-time PCR as described
under Materials and Methods using probe/primer sets
specific to the packaging signal of the MFG-EGFP provirus
or to the housekeeping gene apolipoprotein B (ApoB). We
used the ApoB Ct as a means of sorting out samples that
did or did not have amplifiable DNA in the sample. In all
experiments (Table 1), the mean Ct value for F colonies
was lower than for NF and NT, indicating the presence of
the MFG-EGFP provirus in the F colonies. Fig. 2 displays
the distribution of the F and NT Ct values from all
individual experiments (n = 11). In all but one experi-
ment (BM009), we observed a separation of provirus-
positive samples (clustered at lower Ct values) fromMOLECULAR THERAPY Vol. 11, No. 3, March 2005















provirus-negative samples (clustered near Ct of 40) within
each donor (Fig. 2). Since BM009 lacked the typical
expected Ct cluster of values near 40, it was not
incorporated into the determination of the Ct cutoff.
The choice of the Ct cutoff for provirus presence or
absence could be optimally and consistently obtained by
using the Moloney murine leukemia virus (MMLV) Ct
values derived from NT colonies, which typically cluster
at Ct = 40. For instance, ~87% of the NT colonies (127 of
146 NT colonies) analyzed by the MMLV probe/primer set
were at Ct = 40. We set the Ct cutoff for detection of the
MMLV sequence at 35.9; a simple formula for the
determination of the Ct cutoff for provirus presence
versus absence is outlined under Materials and Methods.
In addition, we compared the ratio of MMLV to ApoB as a
measurement of provirus absence or presence to using
the MMLV Ct alone. However, the ratio did not allow for485
FIG. 2. Distribution of MMLV Ct values for
nontransduced (NT) and fluorescent (F)
colonies. The bar graphs represent the per-
centage of F and NT samples present for each
Ct value. A Ct value of 40 is maximum and is
indicative of the unequivocal absence of
MMLV transgene. Ct values less than 40 were
determined to be PCR+ or PCR based on
statistical analyses of the distribution of the
NT Ct values.
METHOD doi:10.1016/j.ymthe.2004.10.017a consistent Ct cutoff value since the distinction between
the distributions of provirus positive and negative sam-
ples was diminished (data not shown).
Correlation of Transduction Efficiency by Flow
Cytometry, Fluorescence Microscopy, and Real-time
PCR
In 8 of the 11 experiments, we compared transduction
efficiencies determined by flow cytometry, fluorescence
microscopy, and real-time PCR (Table 2). In these experi-
ments, we first monitored the transduction efficiency of
the CD34+-derived cells by flow cytometry and, in
parallel, set up progenitor assays. Approximately 10–14
days later, we determined the transduction efficiency ofTABLE 2: Comparison of transduction efficiency
Expt Flowa Microscopyb Real timec
MPB001 35% 32% 38%
MPB002 44% 47% 46%
BM001 47% 32% 50%
BM002 56% 39% 50%
BM003 51% 48% 60%
BM004 36% 32% 40%
BM005 40% 43% 50%
BM006 26% 39% 51%
Mean F SD 42% F 10% 39 F 7% 48 F 7%
a Flow cytometry was performed 24–72 h following the second day of transduction.
b Fluorescence microscopy was performed on progenitor colonies after 10–14 days of
culture.
c Real-time PCR was performed on progenitor colonies harvested randomly from culture
within 24 h of enumeration via fluorescence microscopy. MPB, G-CSF-mobilized peripheral
blood; BM, bone marrow.
486the progenitors by fluorescence microscopy. Then we
randomly picked progenitors and determined the trans-
duction efficiency by real-time PCR as described above.
The mean transduction efficiency of the bulk population
of CD34+-derived cells as determined by flow cytometry
was 42%. The mean transduction efficiency of colony-
forming units was 39% EGFP+ by fluorescence micro-
scopy and 48% EGFP+ by real-time PCR (Table 2). These
differences were not statistically significant (Kruskal–
Wallis test). In some of the experiments, transduction
efficiency as measured by fluorescence microscopy and
flow cytometry may be slightly underestimated because
of the presence of transduced colonies that did not
express EGFP at detectable levels.
Sensitivity and Specificity of Real-Time PCR
We used ten independent experiments (BM009 was
excluded) with BM or MPB to calculate the sensitivity
and specificity of the real-time PCR method for detection
of integrated provirus in progenitor-derived colonies. We
performed real-time PCR on individual colonies that were
determined by fluorescence microscopy to be F, NF, and
NT. As a representative example, individual Ct values
derived from colonies and controls generated from BM012
are shown in Fig. 3. We considered NF colonies unreliable
and did not use them for determination of specificity
because of possible silencing of the EGFP transgene. We
chose fluorescence microscopy as a positive control
(provirus presence) and used it for the determination of
sensitivity; we chose NT samples as a negative control
(provirus absence) for determination of specificity.MOLECULAR THERAPY Vol. 11, No. 3, March 2005
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IG. 4. ROC curve generated from GEE analysis of Ct values. ROC is generated
om NT and F data. Each point on the curve corresponds to a different
otential Ct cutoff. The area under the curve was 98.1%. A large AUC such as
is indicates potential for high sensitivity and specificity.
FIG. 3. Scatter plot of Ct values for MMLV and ApoB obtained from real-time
PCR analysis of individual progenitor colonies from a representative experi-
ment (BM012). Each colony was analyzed for both MMLV and ApoB
sequences. Ct values for MMLV b 35.9 (dotted line) are positive for the
transgene, while values z35.9 are negative. Bkgd, background methylcellu-
lose samples; NT, nontransduced colonies; F, fluorescent colonies; NF,
nonfluorescent colonies; H2O, buffer control.
METHODdoi:10.1016/j.ymthe.2004.10.017In Table 3, sensitivity and specificity were calculated
using the concordance rates between fluorescence micro-
scopy and real-time PCR with Ct 35.9 as the cutoff point.
Percentage specificity was calculated as the number of
provirus-negative colonies divided by the total number of
nontransduced negative colonies  100. Percentage
sensitivity was calculated as the number of provirus-
positive colonies divided by the total number of micro-
scopy-positive colonies  100. The receiver operator
characteristic (ROC) area under the curve was 98.1%;
with a Ct cutoff of 35.9; this corresponded to less than
5.5% false positives (Fig. 4). We observed high levels of
specificity and sensitivity (95.0 and 90.2%, respectively)
indicating that real-time PCR is a valid assay for assess-
ment of transduction efficiency in progenitor colonies







NT colonies Conventional 50 39
Real time 140 133
F coloniesd Conventional 58 9





NT, nontransduced progenitor colony; F, fluorescent progenitor colony.
a The percentage specificity was calculated as the number of PCR-negative colonies classified a
cutoff point.
b The percentage sensitivity was calculated as the number of PCR-positive colonies classified as
point.
c The false positive rate was calculated as the number of PCR-positive background samples d
d Fluorescent colonies were identified by visual examination using the Axiovert 25 inverted fl
e Background samples were methylcellulose culture medium samples collected from the non
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thConventional PCR vs Real-Time PCR
We compared three experiments with 154 samples using
conventional PCR and 10 experiments with 354 samples
using real-time PCR analysis to assess provirus-positive
and provirus-negative colonies (Table 3). We picked
separate progenitor colonies from the same plates for
analysis by conventional PCR and real-time PCR; we did
not split colonies due to low amounts of DNA. In each
experiment, we plucked samples of F, NF, NT, and
background, prepared them as described under Materials
and Methods, and ran them on the ABI Prism 7700 for
amplification and detection. We compared these samples
to an equivalent number of samples plucked from the
same methylcellulose culture plates but transferred to
Qiagen plates for DNA isolation and PCR analysis by





11 78.0% — —
7 95.0% — —
49 — 84.5% —
193 — 90.2% —
16 — — 22.2%
6 — — 5.8%
s negative divided by total nontransduced negative colonies  100 using the Ct 35.9 as the
positive divided by total microscopy-positive colonies  100 using the Ct 35.9 as the cutoff
ivided by the total number of background samples  100.
uorescence microscope.
colony areas of the plate.
487
METHOD doi:10.1016/j.ymthe.2004.10.017We compared specificity and sensitivity of the two
methods separately using generalized linear models (GEE)
analyses. Odds ratios from GEE analyses present the
magnitude of the differences. The odds ratio is the ratio
of the probability of a correct real-time test divided by the
probability of a correct conventional test (see Materials
and Methods). In the analysis of data from NT samples,
specificity using real-time PCR was significantly higher
compared to conventional PCR as analyzed by GEE ( P =
0.002). For real-time compared to conventional method,
the odds ratio of a provirus-absent sample testing
negative was 5.56 (95% confidence interval 1.85 to
16.73). In the analysis of data from F samples, sensitivity
using real-time PCR was significantly higher compared to
conventional PCR as analyzed by GEE ( P = 0.019). For
real-time compared to conventional method, the odds
ratio of a provirus-present sample testing positive was
1.94 (95% confidence interval 1.11 to 3.37). As shown in
Table 3, for real-time PCR, specificity was 95.0% (exact
95% CI 90.0 to 98.0%) and sensitivity was 90.2% (exact
95% CI 85.4 to 93.8%). For conventional PCR, specificity
was 78.0% (exact 95% CI 64.0 to 88.5%) and sensitivity
was 84.5% (exact 95% CI 72.6 to 92.7%). As hypothe-
sized, the conventional PCR occasionally led to amplifi-
cation of stray cells or DNA not associated with a colony
as evidenced by the presence of bands in 22% of the
background samples (Table 3). The PBS controls in those
experiments were negative, eliminating the possibility of
cross-contamination of reagents. Background samples
from real-time PCR experiments clustered around a Ct
value of 40 with 5.8% false positives (Table 3).
DISCUSSION
Real-time PCR is an attractive method for measuring
gene-transfer efficiency in a large number of samples
simultaneously. Despite its increasing use, no published
study has compared real-time PCR directly with standard
conventional PCR for the detection of transgenes in
hematopoietic progenitor cells. One report determined
gene transfer into hematopoietic progenitor cells by
analyzing individual colonies from a methylcellulose
culture system [9]. In this report, the investigator showed
that real-time PCR was an effective method for detecting
individual transduced progenitor colonies. A high corre-
lation between the real-time PCR fluorescence data and
the visualization of bands on an agarose gel produced
from the real-time PCRs was observed. The real-time PCR
experiments were successfully performed using direct
lysates, demonstrating that no DNA purification or
extraction was necessary and that the presence of small
amounts of methylcellulose did not interfere with the
real-time polymerase chain reactions.
Our study has extended this previous report by
comparing directly the sensitivity and specificity of
conventional PCR with real-time PCR. Our results dem-488onstrate superior sensitivity and specificity of real-time
PCR over conventional PCR in measuring gene-transfer
efficiency into hematopoietic progenitor cells. Sensitivity
may potentially be higher with real-time PCR because of
its more objective readout. Real-time PCR data are
reported as Ct values, while conventional PCR is rela-
tively more subjective than real-time PCR and dependent
on identifying bands on an agarose gel. For smaller
colonies, small amounts of DNA may produce faint bands
or be below the detection level of conventional PCR yet
still be detectable by real-time PCR. Gerard et al. showed
that several colonies that tested positive by real-time PCR
did not produce visible bands when subsequently run on
an agarose gel. In our study, we were able to identify as
few as 10 transduced cell equivalents per PCR (50 cells/
lysate sample) by real-time PCR. Even very small colonies,
which are generally defined as a minimum of 50 cells, can
easily be identified with real-time PCR.
In our study, real-time PCR was also more specific than
conventional PCR in detecting the provirus in progenitor
colonies. The procedure of picking colonies from a
methylcellulose plate can be technically difficult and
the inadvertent capture of stray cells or DNA can result in
false positives. To avoid this error, we plated CD34+ cells
in methylcellulose at a lower cell density (250–1000 cells/
ml), which prevented overcrowding of the plate with
colonies, making it technically easier to pluck colonies
without contamination. In addition, we routinely
plucked progenitor colonies for PCR analysis only if the
plates had fewer than 30 colonies per plate. By applying
the statistical analysis to the distribution of Ct values for
nontransduced colonies to determine the appropriate Ct
cutoff value, a more specific discrimination of positive
colonies was also possible.
There are several sources for potential error with
either method described here. NT colonies may become
PCR positive either from cross-contamination within
the 96-well plate or from integration of wild-type
retroviruses into genomic DNA, which are capable of
binding to the universal primers. Cross-contamination
can be minimized with careful handling and the use of
multichannel pipettes. When utilizing human DNA, it
may be advantageous to use transgene-specific primers
rather than universal primers to avoid recognition of
wild-type viruses. Additionally, very dim or nonexpress-
ing colonies that were successfully transduced with the
EGFP retrovirus may be read out as NF, thereby causing
an artificially increased false positive rate. Fluorescent
colonies may be PCR negative if the transgene is absent
but the colony produces some degree of autofluores-
cence, as can be seen in apoptotic cells. False positives
can occur if stray transduced cells or DNA is inadver-
tently collected in the process of plucking of negative
colonies. Finally, distinguishing primer dimers from
weakly positive samples can be problematic, especially
in real-time PCR, in which a gel is not routinely run.MOLECULAR THERAPY Vol. 11, No. 3, March 2005
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METHODdoi:10.1016/j.ymthe.2004.10.017To avoid high levels of primer dimers routinely
observed in negative control samples that do not
contain DNA, we utilized nontransduced cells as the
negative control.
Because real-time PCR is relatively automated and
capable of analyzing many samples simultaneously, it
remains an attractive tool for the measurement of trans-
duction efficiency. The technology is especially applica-
ble to human gene therapy clinical trials, in which PCR is
performed on a large number of patient samples and
repeated regularly. With the described technique of
analyzing real-time PCR progenitor colony data, a more
accurate assessment of transduction efficiency is possible.
MATERIALS AND METHODS
Isolation of bone marrow and mobilized peripheral blood CD34+ cells.
BM and G-CSF-mobilized MPB samples were obtained from healthy
adult volunteers after obtaining informed consent. for samples collected
at the Cincinnati Children’s Hospital Medical Center (n = 8), the
protocol utilized was approved by the Institutional Review Board of
Cincinnati Children’s Hospital Medical Center. For samples collected at
Indiana University (n = 3), the protocol utilized was approved by the
Institutional Review Board at the Indiana University School of
Medicine. The bone marrow samples were filtered through a 40-Am
cell strainer and then diluted 1:1 with Hanks’ balanced solution
(GIBCO BRL, Grand Island, NY, USA). Low-density (b1.077 g/cm3) cells
were isolated by centrifugation at 1700 rpm for 30 min (without brake)
at room temperature on Ficoll–Hypaque (Sigma, St. Louis, MO, USA)
and then washed once in phosphate-buffered saline (PBS). Residual red
blood cells were lysed with lysis buffer (0.1 mM EDTA, 10 mM KHCO2,
155 mM NH4CL in PBS). The cells were then resuspended in magnetic-
activated cell sorting (MACS) buffer (5 mM EDTA, 0.5% bovine serum
albumin (BSA) in PBS, PH 7.2). CD34+ cells were isolated using the
CD34 progenitor cell isolation kit and Vario MACS separator (Miltenyi
Biotech, inc., auburn, ca, usa) according to the manufacturer’s
instructions. Following CD34 isolation, the cells were immediately
placed into culture as described below. For isolation of MPB CD34+
cells, volunteers were treated for 5 days with subcutaneous human G-
CSF (Amgen, Thousand Oaks, CA, USA) at 5 Ag/kg/day as previously
described [10]. On day 5 of treatment, white blood cells were collected
by apheresis and CD34+ cells were isolated by immunomagnetic
methods with the Isolex 300SA cell selection device according to the
manufacturer’s instructions (Baxter, Irvine, CA, USA). These samples
were cryopreserved in aliquots of 3  106 cells in 90% fetal calf serum
(FCS) + 10% dimethyl sulfoxide (Sigma) and later thawed for use in
gene transfer experiments. CD34 purity ranged from 75 to 95%. For
determination of purity, isolated cells were stained with an allophyco-
cyanin-conjugated anti-CD34 antibody (clone 581) (BD Biosciences
Pharmingen, San Jose, CA, USA) and the percentage CD34+ was
determined by flow cytometry.
Generation of gibbon ape leukemia virus (GALV)- and
RD114-pseudotyped MFG-EGFP. The MFG-EGFP retrovirus vector
expresses the EGFP under the control of the MMLV long terminal repeat
and has been previously described [11]. For generation of the GALV-
pseudotyped vector, supernatant from an amphotropic MFG-EGFP clone
was used to infect the PG13 packaging cell line (American Type Culture
Collection, Manassas, VA, USA) [12]. Pooled supernatant from PG13 cells
was then collected and used for transduction. Vector particles pseudo-
typed with feline endogenous virus (RD114) were derived from the
packaging cell line FLYRD18 [13] (kindly provided by Mary Collins,
Chester Beatty Laboratories, London, UK). An amphotropic MFG-EGFP
clone was used to infect FLYRD18 cells and the resultant supernatant was
used for transduction. The titers of the supernatants were calculated byMOLECULAR THERAPY Vol. 11, No. 3, March 2005
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h after end-point dilution of the supernatant. Titers of supernatants
utilized in experiments described here were 2  105/ml (GALV) and 5 
105/ml (RD114).
Transduction of CD34+ cells. Isolated CD34+ cells were prestimulated
with cytokines at a cell density of 4  105/ml in Iscove’s modified
Dulbecco’s medium (IMDM) (GIBCO BRL) containing 10% FCS and 1%
penicillin–streptomycin (referred to as complete medium—CM). The
cytokines used were G-CSF (Amgen), stem cell factor (SCF) (Amgen), and
megakaryocyte growth and development factor (Amgen; all at 100 ng/
ml), referred to as G/S/M. Non-tissue-culture 24-well plates were coated
with 8 Ag/cm2 fibronectin (CH-296) (Takara Shuzo, Otsu, Japan) for 2 h
at room temperature as previously described [14,15]. The wells were
blocked with 2% BSA (Roche, Indianapolis, IN, USA) for 20 min and
washed once with PBS. Cells (2  105) suspended in 1 ml CM + G/S/M
were added to 1 ml of viral supernatant in each CH-296-coated well. The
multiplicity of infection was 1.0 for transductions performed with GALV
and 2.5 for transductions with RD114. The cells were transduced for 4 h
at 378C, 5% CO2 and then the CM + supernatant was replaced with fresh
CM + G/S/M for incubation overnight. A second transduction was
performed the following day in an identical fashion. BMD003 and
BMD009 were transduced with the RD114-pseudotyped vector. All other
experiments utilized the GALV-pseudotyped vector. Twenty-four hours
after the second transduction, the cells were harvested, counted, and
transferred into progenitor assays. An aliquot of the transduced cells was
resuspended in CM + G/S/M for an additional 24–72 h and then
analyzed by flow cytometry to determine %EGFP+ cells.
Progenitor assays. Progenitor assays were performed 24 h after the
second day of transduction in complete methylcellulose medium
(Methocult GF, H4434; Stem Cell Technologies, Inc.) containing SCF
(50 ng/ml), interleukin-3 (10 ng/ml), granulocyte–macrophage-CSF
(10 ng/ml), and erythropoietin (3 units/ml). The cells were seeded
onto 35-mm dishes in triplicate at concentrations of 250, 500, and
1000 cells/ml and incubated at 378C in 5% CO2. After 10–14 days of
incubation, colony-forming units–granulocyte–macrophage, burst-form-
ing units–erythroid, and colony-forming units–mixed lineage were
enumerated using the Axiovert 25 inverted fluorescence microscope.
Direct visualization of fluorescence from colonies was used to
determine transduction efficiency.
Real-time PCR. Fifty microliters of crude PCR cell lysing buffer
consisting of 1 PCR buffer, 0.5% NP-40 (Sigma), 0.5% Tween 20
(Sigma), and 0.91 mg/ml proteinase K (Boehringer Mannheim,
Mannheim, Germany) was delivered to each well of a 96-well optical
plate (Applied Biosystems, Foster City, CA, USA) using a repeating
pipettor. Under a fluorescence microscope, single progenitor colonies
growing in methylcellulose were harvested using a P-10 pipette set at
3.0 Al and transferred directly into the 96-well plate containing the
crude cell lysing buffer. Approximately 20 F colonies and 20 NF
colonies (each from transduced cultures) and 20 NT colonies were
collected and labeled. bBackgroundQ methylcellulose samples obtained
from noncolony areas of the plates and samples containing cell lysis
buffer alone were analyzed as negative controls. After all colonies were
transferred, the plate was covered with an optical adhesive (Applied
Biosystems) and placed in a thermal cycler (Applied Biosystems) for 1 h
at 608C followed by 15 min at 958C. Ten microliters of cell lysate from
each well was then transferred to each corresponding well of a new 96-
well plate previously loaded with 40 Al per well PCR master mix. The
preparation of the PCR master mix and the addition of the cell lysates
were performed under a hood in a dedicated PCR room and filter
barrier pipet tips were used to prevent aerosol contamination. After all
the cell lysates were transferred to the fresh 96-well plate, the plate was
covered with a new optical adhesive (Applied Biosystems) and placed
in the real-time PCR machine (ABI Prism 7700 sequence detection
system, PE Applied Biosystems) for amplification and detection.
The ABI Prism 7700 sequence detection system (PE Applied Biosys-
tems) along with a MMLV universal probe/primer set was utilized to detect489
METHOD doi:10.1016/j.ymthe.2004.10.017the presence of the integrated MFG-EGFP provirus in individual colonies.
This universal probe/primer set has been previously shown to recognize
the packaging sequence in numerous MMLV-derived vectors including the
MFG vector [8,11]. The forward primer (MMLV-F, 5V-CGCAACCCTGGGA-
GACGTCCC-3V) and the reverse primer (MMLV-R, 5V-CGTCTCCTACCA-
GAACCACATATCC-3V) amplified a 134-bp fragment of the packaging
signal. Amplification was detected with a FAM-labeled probe (6FAM–5V-
CCGTTTTTGTGGCCCGACCTGAGG-3V–TAMRA) internal to the PCR
product. To minimize false negatives, the human ApoB gene was used as
an internal control for DNA content and quality was analyzed concur-
rently. The forward primer ApoB-F (5V-TGAAGGTGGAGGACATTCCTCTA-
3V) and the reverse primer ApoB-R (5V-CTGGAATTGCGATTTCTGGTAA-3V)
were used and amplification was detected with a VIC-labeled internal
probe (VIC–5V-CGAGAATCACCCTGCCAGACTTCCGT-3V–TAMRA). Sam-
ples that did not contain the ApoB sequence were removed from the
analysis. Negative controls included NT colonies, background methyl-
cellulose samples, cell lysis buffer, and injectable water.
Statistical analysis for determination of Ct cutoff value. Data were
collected in separate experiments from 11 bone marrow donors. BM009
lacked the typical expected Ct cluster of values near 40; therefore, it was
not included in the analysis to determine the Ct cutoff value. EGFP-
positive and NT progenitor colonies were analyzed. Since the EGFP
transgene was known to be absent in nontransduced samples, these
samples served as the background control for determination of the Ct
cutoff. Samples with an ApoB Ct of 40 or greater were interpreted as
having an inadequate amount of DNA and removed from the analysis.
To standardize the Ct cutoff for all experiments, the threshold (level of
fluorescence for a given Ct value) was set at the computer default
setting. In two experiments, this was adjusted slightly higher to avoid
assigning an inappropriately low Ct value to a sample that was clearly
negative based on the computer-generated graph. A Ct value of 40 is the
default setting on the machine for a negative sample since after 40
cycles of amplification, if DNA still has not been detected, it is assumed
absent.
Due to some overlap between the Ct measurements of transgene-
present and -absent samples, the cutoff Ct value would unavoidably
produce some number of false positives and negatives. Determination of
the Ct cutoff was therefore based on the priority of minimizing false
positives while maintaining sensitivity greater than 70%. A statistical
analysis of the Ct values from NT control samples was used to develop a
threshold Ct value-based test to determine which progenitor-derived
colonies exposed to retrovirus were PCR positive. An individual colony
was determined to be PCR positive if its Ct value for the EGFP transgene
was less than 35.9. The threshold of 35.9 was selected based on
distributions of the NT negative control Ct values and ROC curve (Fig.
4). The ROC curve is a plot of sensitivity vs false positive rate with area
under the curve (AUC) as a measure of test accuracy. Points on the curve
correspond to probabilities of gene presence and to all possible
diagnostic cut-points for values of sensitivity and false positive rate.
Approximately normal distributions at lower Ct values were consistently
observed in the gene-present (i.e., EGFP-positive) samples for each
donor. However, means varied considerably between donors. In contrast,
gene-negative data were typically at or near Ct of 40. The consistency of
the NT data (Fig. 2), together with the study priority of minimizing false
positives, resulted in the choice of cutoff based on ranked gene-absent
data. Data from one experiment (BM009) were very atypical and were
therefore not incorporated into the determination of the Ct cutoff. To
generate points for the ROC curve, GEE was used since multiple samples
from the same donor are correlated. In this analysis, probability of gene
presence was predicted by Ct value adjusted for donor. A Ct threshold of
35.9 was found to correspond to less than 5.5% false positives. This
analysis was a robust nonparametric rank-based approach appropriate for
expected experimental data distributions. Accordingly, an individual
colony was determined to be PCR positive if its Ct value generated using
the MMLV probe/primer set was less than 35.9.
Simple formula for determination of Ct cutoff. We developed a method
for determining a Ct cutoff value based on a false positive rate of less than4905.5%. For a given probe/primer set, the Ct values from a minimum of 62
nontransduced samples should be analyzed. This is based on the statistical
analysis of the proportion of Ct values of 40 for nontransduced samples.
Data from an experiment without a large percentage of Ct near the default
value of 40, such as BM009, must be excluded, since they would not meet
the distributional requirements of the real-time method. The following
formula can be used to estimate the Ct cutoff from nontransduced test
samples:
(1) Rank Ct values from minimum to maximum.(2) Multiply number of samples by 0.055. Round down to integervalue. This is the rank of the sample that will be used for the Ct
cutoff.(3) Obtain cutoff value by rounding down to 1 decimal point.(4) Positives are b new cut-point and negatives are z new cut-point.For example, given that the number of test nontransduced samples =
67:
(1) Rank by C t values (34.71, 35.54, 37.32, 38.93, 39.1, 39.7,remainder 40.00).(2) 67  0.055 = 3.685. Round down to 3. Select third from lowest Ct
value, 37.32.(3) Round to 1 decimal to obtain cut-off of 37.3.(4) Positives have Ct b 37.3 and negatives have Ct z 37.3.Conventional PCR. DNA was isolated using the QIAamp 96 spin blood kit
(Qiagen, Valencia, CA, USA) as per the manufacturer’s instructions with
minor modifications. Colonies were picked from methylcellulose as
described above, but transferred directly to the 96-well block prefilled
with 200 Al per well of PBS. Approximately 20 F, 20 NF, and 20 NT
colonies were picked per donor sample and transferred and labeled
accordingly. Twenty-five microliters of Qiagen protease and 200 Al of
buffer AL were added to each sample and the wells were sealed tightly
with caps. The samples were mixed thoroughly by shaking and then spun
at 3000 rpm briefly. The block was incubated at 708C and respun to collect
any condensate from the caps. Two hundred ten microliters of 100%
ethanol was added and then mixed by shaking after reapplying the caps.
The QIAamp 96 plate was placed on top of a new block. The mixture from
the original block was then transferred to the QIAamp 96 plate and then
spun at 6000 rpm for 4 min. Five hundred microliters of buffer AW1 was
then added and the samples were respun at 6000 rpm for 2 min. Five
hundred microliters of buffer AW2 was added and the samples were
respun at 6000 rpm for 2 min. The plate was then placed on top of a
microtube collection rack and incubated at 708C for 10 min. One hundred
microliters of Tris buffer (10 mM, pH 8.0) (Sigma) was then added to each
well. The samples were incubated at room temperature for 5 min and then
spun at 6000 rpm for 4 min. DNA was stored at 48C. Two PCRs were
performed for each sample, one using MMLV primers and a second using
the h-globin forward primer (5V-CAATCCAGCTACCATTCTGC-3V) and the
h-globin reverse primer (5V-GAATCCAGATGCTCAAGGCC-3V). Thirty
microliters of DNA was used for MMLV PCR and 10 Al of DNA for the
h-globin PCR. Each sample was amplified with both sets of primers and
run on 2% agarose gels separately.
Determination of the minimal number of cells required for real-time
PCR detection. The HEL cell line containing ~1 copy of the MFG-EGFP
provirus (HEL-EGFP-1) per genome was generated by transducing HEL cells
with a limiting dilution of supernatant containing the GALV-pseudotyped
MFG-EGFP retroviral vector to yield a cell population that was ~5% EGFP+.
The EGFP+ cells were then sorted by flow cytometry and expanded.
Genomic Southern analysis with a MFG-EGFP vector copy number
standard indicated that the copy number was ~1 copy per genome
equivalent (data not shown). Cells from the HEL-EGFP-1 cell line, which
were transduced with a single copy of the EGFP gene using the MFG-GALV
vector, were enumerated with the automated particle counter (Coulter Z1;MOLECULAR THERAPY Vol. 11, No. 3, March 2005
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METHODdoi:10.1016/j.ymthe.2004.10.017Beckman/Coulter, Hialeah, FL, USA) and prepared by limiting dilution.
The cells were suspended in IMDM in concentrations ranging from 1  106
to 1  103 cells/ml to allow analysis of the following samples of cell
numbers: 10,000, 5000, 1000, 500, 100, 50, and 10. Ten microliters from
each concentration was added to 40 Al of crude cell lysing buffer in a 96-
well plate (Applied Biosystems). The plate was covered and placed in a
thermal cycler (Applied Biosystems) and heated at 608C for 1 h and 958C
for 15 min. Ten microliters of the cell lysate from each well was then
analyzed using the ABI Prism 7700 exactly as performed with colony cell
lysates as described above. Nontransduced HEL cells and IMDM were used
as negative controls.
Statistical analyses. Statistical analyses were performed using SAS version
8.02 and ROC graphs were created using STATA version 8.2. Statistical
tests were performed as two-tailed at the 0.05 significance level.
Sensitivity and specificity are presented with exact 95% confidence
intervals for real-time and conventional PCR. Real-time and conventional
methods were tested for differences in specificity and sensitivity using
GEE. GEE analysis was necessary to account for correlation between
repeated samples from the same donor [16]. Typically, samples obtained
from a single donor will be more similar than samples obtained from
different donors. If positive correlations among each donor’s samples
were ignored, the standard error of the parameter estimate would be too
small and type I error would be inflated. Separate comparisons of
specificity and sensitivity between the two methods were performed
using population-averaged generalized linear models. The correlation
structure was assumed to be exchangeable. ROC curve was generated
using GEE analysis of the fluorescent and nontransduced sample data sets.
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